Cargando…

Utilizing BMP-2 muteins for treatment of multiple myeloma

Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor β (TGFβ) member Activin A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seher, Axel, Lagler, Charlotte, Stühmer, Thorsten, Müller-Richter, Urs Dietmar Achim, Kübler, Alexander Christian, Sebald, Walter, Müller, Thomas Dieter, Nickel, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425150/ https://www.ncbi.nlm.nih.gov/pubmed/28489849 http://dx.doi.org/10.1371/journal.pone.0174884

Ejemplares similares

The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent
por: Lagler, Charlotte, et al.
Publicado: (2017)

Biological activity of a genetically modified BMP-2 variant with inhibitory activity
por: Klammert, Uwe, et al.
Publicado: (2009)

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor
por: Weber, Dionys, et al.
Publicado: (2007)

The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy
por: Scheurer, Mario Joachim Johannes, et al.
Publicado: (2019)

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
por: Heinecke, Kai, et al.
Publicado: (2009)

MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes
por: Braun, Andreas, et al.
Publicado: (2012)

Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro
por: Seher, Axel, et al.
Publicado: (2011)

Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment
por: Müller-Richter, Urs Dietmar Achim, et al.
Publicado: (2017)

GDF-5 can act as a context-dependent BMP-2 antagonist
por: Klammert, Uwe, et al.
Publicado: (2015)

A Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor Promiscuity
por: Harth, Stefan, et al.
Publicado: (2010)

Specification of BMP Signaling
por: Nickel, Joachim, et al.
Publicado: (2019)

Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein
por: Lu, Daniel R, et al.
Publicado: (2020)

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
por: Brands, Roman C., et al.
Publicado: (2019)

Vermilion Reconstruction with Genital Mucosa
por: Müller-Richter, Urs D.A., et al.
Publicado: (2016)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation – An Appraisal
por: Steinbrunn, Torsten, et al.
Publicado: (2014)

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
por: Ma, Shining, et al.
Publicado: (2023)

Mutations in GDF5 Reveal a Key Residue Mediating BMP Inhibition by NOGGIN
por: Seemann, Petra, et al.
Publicado: (2009)

A novel Mutein of TNFα Containing the Arg-Gly-Asp Sequence Shows Reduced Toxicity in Intestine
por: Shikama, H., et al.
Publicado: (1994)

A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
por: Lee, Saehyung, et al.
Publicado: (2019)

Evaluation of Adverse Effects of Mutein Forms of Recombinant Human Interferon Alpha-2b in Female Swiss Webster Mice
por: Rachmawati, H., et al.
Publicado: (2013)

A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
por: Peterson, Laurence B., et al.
Publicado: (2018)

A simple approach for preparation of affinity matrices: Simultaneous purification and reversible immobilization of a streptavidin mutein to agarose matrix
por: Wu, Sau-Ching, et al.
Publicado: (2017)

Receptor-selective interleukin-4 mutein attenuates laser-induced choroidal neovascularization through the regulation of macrophage polarization in mice
por: Gao, Limo, et al.
Publicado: (2021)

The antitumor effect induced by an IL-2 ‘no-alpha’ mutein depends on changes in the CD8(+) T lymphocyte/Treg cell balance
por: Carmenate, Tania, et al.
Publicado: (2022)

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

Development of a Tetrameric Streptavidin Mutein with Reversible Biotin Binding Capability: Engineering a Mobile Loop as an Exit Door for Biotin
por: O'Sullivan, Valerie J., et al.
Publicado: (2012)

Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
por: Ghelani, Aazam, et al.
Publicado: (2020)

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein
por: Munoz Pinto, Mario F, et al.
Publicado: (2021)

Binding between Crossveinless-2 and Chordin Von Willebrand Factor Type C Domains Promotes BMP Signaling by Blocking Chordin Activity
por: Zhang, Jin-Li, et al.
Publicado: (2010)

A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
por: Kraich, Michael, et al.
Publicado: (2006)

An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report
por: Hartmann, Stefan, et al.
Publicado: (2014)

Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein
por: de Picciotto, Seymour, et al.
Publicado: (2022)

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2020)

The Clip-Segment of the von Willebrand Domain 1 of the BMP Modulator Protein Crossveinless 2 Is Preformed
por: Fiebig, Juliane E., et al.
Publicado: (2013)

The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines
por: Fiedor, Elżbieta, et al.
Publicado: (2016)

A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2
por: Chen, Xi, et al.
Publicado: (2018)

Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma
por: Fiedor, E., et al.
Publicado: (2017)

A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy
por: Chen, Alex C., et al.
Publicado: (2020)

Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells
por: Inoue, Masaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7qoisvfch6p8orfqhq2d6qs1nm